
Consumers and providers were asked for their thoughts on the state of health care and how they are navigating this evolving landscape during the coronavirus 2019 (COVID-19) pandemic.

Consumers and providers were asked for their thoughts on the state of health care and how they are navigating this evolving landscape during the coronavirus 2019 (COVID-19) pandemic.

Favipiravir is not approved by the FDA. It is being researched in the United States as a potential treatment of COVID-19.

Data show that immunotherapy doesn’t necessarily worsen complications for patients with both COVID-19 and cancer.

Poor cardiorespiratory fitness can lead to premature death and high blood pressure.

Both REM and non-REM sleep contribute to visual learning and overall brain health.

The review also summarized proposed mechanisms behind these wide-ranging systemic effects and provided clinical guidance for physicians, according to a press release.

The test is intended to determine whether someone is currently infected with COVID-19 and if they have been infected in the past.

Without an FDA approved treatment or vaccine for COVID-19, masks are the best form of protection, according to the CDC.

Steven C. Anderson, FASAE, CAE, IOM, president and CEO of the National Association of Chain Drug Stores, has been invited to join the office of Health and Human Services’ new COVID-19 Vaccine Consultation Panel.

Status reaffirms PTCE as the leader in continuing pharmacy education

The combination medication is used to treat the symptoms of tension or muscle contraction headaches. The drug is only available via a prescription from a physician.

In addition to its potential uses in cancer treatment, this novel drug delivery system could be used with magnetic resonance imaging or fluorescence imaging.

Exercise found to reduce the risk of high blood pressure even in polluted areas.

How a pharmacy performs with respect to specific measures can be associated with a DIR fee.

As increasing numbers of COVID-19 patients require intubation, aerosol containment devices have been in high demand, including improvised protection strategies and devices.

Esketamine shows promise for adults suffering from treatment-resistant depression.

Pharmacists are central health care professionals in medication therapy management and play a crucial role in improving life quality outcomes among patients.

The Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) study has played a key role in helping the health care industry look closer at the disproportionate risk of comorbidities, such as chronic liver and kidney disease, physical function impairment and frailty, premature reproductive aging, and cancer in patients with HIV.

Regional and state access assistance, improved research and collaboration, and individualized options for patients are key factors in adherence to PrEP.

Phase 1/2 trials show promising results as the study moves into phase 2/3.

Along with the duty to care for patients with COVID-19 is the psychological burden that develops in frontline care professionals, such as pharmacists.

Globally, dolutegravir is expected to be a part of treatment for approximately 15 million people living with HIV by 2021.

Although shingles can affect any age group, risks increase with age.

Contrary to earlier data, a new study from the University of California at San Francisco (UCSF) suggests that younger age may not reduce the severity of coronavirus disease 2019 (COVID-19).

The new report intends to change the practices in the HIV/coinfections research community so that women, providers, and policy makers can make evidence-based decisions regarding the use of medications during pregnancy.

Can nitroglycerin patches be used to treat tendonitis?

The goal of the current format for retail pharmacy services is to continue providing people with the medications they need to maintain their health and longevity during the coronavirus disease 2019 pandemic.

Investigators have found that shear stress caused by aortic valve stenosis activates white blood cells, leading to potentially harmful inflammation, which in turn accelerates heart disease.

As a chronic respiratory disease, asthma has been considered a risk factor for COVID-19 by many experts and clinicians.

Published in the American Journal of Respiratory and Critical Care Medicine, the latest ATS practice guideline maintains the first principle of clinical practice, that “all patients who use tobacco should receive treatment for their dependence, and not simply be encouraged to stop.”